Allogene Therapeutics has appointed Susan Lundeen as its chief people officer. Lundeen was previously chief human resources officer at Unity Biotechnology. Before that, she served as SVP of human resources at Kythera Biopharmaceuticals and held several roles at Amgen.
“As we plan for our first pivotal trial, expand our pipeline and scale our operations, we need an experienced chief people officer with a proven capability to develop and align our human resources strategy with our business strategy,” said David Chang, president, CEO and co-founder of Allogene, in a statement. “We want to continue building a world-class environment for our employees and our business to thrive. Susie’s wealth of experience will be instrumental to the future success of Allogene.”
